Complimentary webinar with the DEA on Controlled Substances!

During this global pandemic, the Diversion Control Division is working to assure that there is an adequate supply of controlled substances in the United States, while preventing the diversion of these controlled substances.

To help every link of the supply chain understand DEA’s tools and role during these unprecedented times, ACI invites you to join the complimentary webinar to learn firsthand about the guidance documents and exceptions to regulations that DEA has issued.

Join the discussion with leaders of the industry:

• Claire M. Brennan, Section Chief, Liaison Section, Diversion Control Division, Drug Enforcement Administration
• Scott A. Brinks, Section Chief, Regulatory Drafting & Policy Support Section, Diversion Control Division, Drug Enforcement Administration
• Hunter DeKoninck, Attorney, Quarles & Brady LLP
• Rick Hartunian, Partner, Manatt, Phelps & Phillips, LLP

Topics will include:

• Reviewing DEA’s COVD-19 responses

• Identifying challenges for suspicious order monitoring during the global pandemic

• Overcoming due diligence roadblocks during social distancing

Click here to see the details »